![]() |
|||
|
|
|||
|
|
home > articles > copd & lung disorders > nebulized glutathione induces bronchoconstriction in patients with mild asthma Glutathione Articles - COPD (Chronic Obstructive Pulmonary Disease) & Lung Disorders
Nebulized Glutathione Induces Bronchoconstriction in Patients with Mild
Asthma To assess the effects on
bronchial responsiveness of nebulized glutathione (GSH), one of the most
efficient scavengers of oxidant substances in the airways, we studied
eight patients with mild asthma (FEV1 , 88 +/- 11% predicted [SD]) in a
randomized, double-blind, cross-over, placebo-controlled fashion.
Bronchial challenge was measured using both FEV1 and total pulmonary
resistance (Rrs) by the forced oscillation technique. Patients received
nebulized GSH (600 mg with 4 ml of 0.9% sodium chloride) or placebo
(identical saline solution) over a period of 25 min, 1 wk apart. Placebo
provoked subclinical mild bronchoconstriction (changes from baseline:
FEV1, -1%; Rrs, + 17%); by contrast, GSH caused major airway narrowing
(changes from baseline: FEV1 ,-19%; Rrs,+ 61%) and |
|
|
|
![]() |
||